Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for staphylococcus aureus virulence

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Josefsson, Elisabet ^a   Higgins, Judy ^b   Foster, Timothy J ^b   Tarkowski, Andrej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BACTERIAL PROTEIN; CLUMPING FACTOR A P336; CLUMPING FACTOR A Y338; FIBRINOGEN; IMMUNOGLOBULIN G; INTERLEUKIN 6; RECOMBINANT CLUMPING FACTOR A; RECOMBINANT PROTEIN; SERINE; AMINO ACID; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BINDING SITE; CONTROLLED STUDY; DISEASE SEVERITY; INFLAMMATION; MOUSE; MUTATION RATE; NONHUMAN; PROTEIN BINDING; PROTEIN BLOOD LEVEL; STAPHYLOCOCCUS AUREUS; WILD TYPE; ANIMAL; CHEMISTRY; INFECTIOUS ARTHRITIS; METABOLISM; PATHOGENICITY; SEPSIS; VIRULENCE;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

AMINO ACIDS; ANIMALS; ARTHRITIS, INFECTIOUS; BINDING SITES; COAGULASE; FIBRINOGEN; MICE; SEPSIS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 48249107445     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002206     Document Type: Article

References (22)

1. Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, et al. (2002) Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun 70: 4987-4996.
2. McDevitt D, Nanavaty T, House-Pompeo K, Bell E, Turner N, et al. (1997) Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur J Biochem 247: 416-424.
3. McDevitt D, Francois P, Vaudaux P, Foster TJ (1994) Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 11: 237-248.
4. Palmqvist N, Patti JM, Tarkowski A, Josefsson E (2004) Expression of staphylococcal clumping factor A impedes macrophage phagocytosis. Microb Infect 6: 188-195.
5. Higgins J, Loughman A, van Kessel KPM, van Strijp JAG, Foster TJ (2006) Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Micriobiol Lett 258: 290-296.
6. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, et al. (2005) Roles of fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 57: 804-818.
7. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, et al. (2002) Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 44: 1033-1044.
8. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T (2001) Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 184: 1572-1580.
9. Palmqvist N, Foster T, Fitzgerald R, Josefsson E, Tarkowski A (2005) Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. J Inf Dis 191: 791-798.
10. Deivanayagam CCS, Wann ER, Chen W, Carson M, Rajashankar KR, et al. (2002) A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen-binding MSCRAMM, clumping factor A. The EMBO Journal 21: 6660-6672.
11. Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A (1991) Experimental Staphylococcus aureus arthritis in mice. Infect Immun 59: 2615-2623.
12. Sakiniene E, Bremell T, Tarkowski A (1996) Addition of corticosteroids to antibiotic treatment ameliorates the course of experimental Staphylococcus aureus arthritis. Arthritis Rheum 39: 1596-1605.
13. Verdrengh M, Tarkowski A (1997) Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65: 2517-2521.
14. Weineisen M, Sjöbring U, Fällman M, Andersson T (2004) Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J Immunol 172: 3798-3807.
15. Sandin C, Carlsson F, Lindahl G (2006) Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol 59: 20-30.
16. Duthie ES, Lorenz LL (1952) Staphylococcal coagulase: mode of action and antigenicity. J Gen Microbiol 6: 95-107.
17. Kreiswirth BN, Löfdahl S, Betley MJ, O'Reilly M, Schlievert PM, et al. (1983) The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305: 709-712.
18. Foster TJ (1998) Molecular genetic analysis of staphylococcal virulence. In: Williams P, Ketley J, Salmond G, eds. Methods in Microbiology Vol 27: Bacterial Pathogenesis. London: Academic Press. pp 433-454.
19. 2++ -dependent inhibitory site. J Biol Chem 273: 6821-6829.
20. Sakiniene E, Bremell T, Tarkowski A (1999) Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin Exp Immunol 115: 95-102.
21. Mancini G, Carbonara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235-254.
22. Bremell T, Abdelnour A, Tarkowski A (1992) Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 60: 2976-2985.